Changeflow GovPing Pharma & Drug Safety EPO Patent Application: Recombinant Microorgani...
Routine Notice Added Final

EPO Patent Application: Recombinant Microorganism for Cannabidiolic Acid Production

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026029310A1 concerning a transformed recombinant microorganism capable of producing cannabidiolic acid. The application details the microorganism and a method for its use in producing the compound.

What changed

The European Patent Office (EPO) has published patent application EP2026029310A1, titled 'TRANSFORMED RECOMBINANT MICROORGANISM CAPABLE OF PRODUCING CANNABIDIOLIC ACID, AND METHOD FOR PRODUCING CANNABIDIOLIC ACID BY USING SAME'. This application, published on March 18, 2026, relates to a specific type of genetically modified microorganism designed for the production of cannabidiolic acid and the method for utilizing it. The application lists several inventors but notes that their designation has not yet been filed.

This publication represents a new patent application filing and does not impose immediate compliance obligations on regulated entities. Companies involved in biotechnology, pharmaceutical manufacturing, or the production of cannabinoids should monitor this patent application for potential future intellectual property rights and commercial implications. The application is designated for several European countries, indicating a broad geographic scope within the EU.

Source document (simplified)

← EPO Patent Bulletin

TRANSFORMED RECOMBINANT MICROORGANISM CAPABLE OF PRODUCING CANNABIDIOLIC ACID, AND METHOD FOR PRODUCING CANNABIDIOLIC ACID BY USING SAME

Publication EP2026029310A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 15/81 20060101AFI20260208BHEP C12N 9/02 20060101ALI20260208BHEP C12P 7/42 20060101ALI20260208BHEP C12R 1/84 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

TRANSFORMED RECOMBINANT MICROORGANISM CAPABLE OF PRODUCING CANNABIDIOLIC ACID, AND METHOD FOR PRODUCING CANNABIDIOLIC ACID BY USING SAME

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026029310A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Biotechnology Research Drug Manufacturing
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.